| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |